tiprankstipranks
Trending News
More News >
Joint Corp (JYNT)
NASDAQ:JYNT
US Market
Advertisement

Joint (JYNT) Earnings Dates, Call Summary & Reports

Compare
268 Followers

Earnings Data

Report Date
Mar 05, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.04
Last Year’s EPS
-0.18
Same Quarter Last Year
Moderate Buy
Based on 5 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative aspects. The company showed growth in revenue and EBITDA, along with strong cash reserves and progress in refranchising. However, challenges such as declining sales metrics and revised guidance due to economic headwinds were noted.
Company Guidance
During the Joint Corporation's Third Quarter 2025 Financial Results Conference Call, several key metrics and strategic initiatives were discussed. Revenue from continuing operations grew by 6% compared to Q3 2024, while consolidated adjusted EBITDA increased by 36%. However, system-wide sales declined by 1.5%, and comp sales were down 2%. The company repurchased $5 million worth of stock since the last conference call, and the Board has authorized an additional $12 million for the stock repurchase plan. Unrestricted cash and cash equivalents were reported at $29.7 million as of September 30, 2025. The company aims to drive new patient acquisition and improve financial positions through a national marketing campaign, digital enhancements, and a 3-tiered pricing pilot for their wellness plan. Additionally, they are focused on refranchising corporate clinics and have entered an agreement to sell 45 corporate clinics in Southern California for $4.5 million. The company expects system-wide sales for the full year 2025 to range from $530 million to $534 million and predicts comp sales to be between negative 1% and flat. They are maintaining guidance for consolidated adjusted EBITDA to be between $10.8 million to $11.8 million.
Revenue and EBITDA Growth
Revenue from continuing operations increased by 6%, and consolidated adjusted EBITDA increased by 36% compared to Q3 2024.
Stock Repurchase and Cash Position
Repurchased $5 million of stock since the last conference call, with an additional $12 million authorized. Unrestricted cash and cash equivalents were strong at $29.7 million.
Digital Marketing and Technology Initiatives
Launched a national marketing campaign and strengthened digital marketing efforts with SEO improvements, resulting in a 20% to 40% increase in organic search traffic. Patient-facing mobile app adoption reached 18% of new patients with over 178,000 downloads.
Progress in Refranchising Strategy
Entered into an agreement to sell 45 corporate clinics in Southern California for $4.5 million, with ongoing negotiations for the remaining 33 corporate clinics.

Joint (JYNT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

JYNT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 05, 2026
2025 (Q4)
0.04 / -
-0.18
Nov 06, 2025
2025 (Q3)
0.02 / 0.02
-0.21109.52% (+0.23)
Aug 07, 2025
2025 (Q2)
-0.04 / -0.05
-0.2477.92% (+0.19)
May 08, 2025
2025 (Q1)
<0.01 / -0.03
0.06-150.00% (-0.09)
Mar 13, 2025
2024 (Q4)
0.01 / -0.18
-0.7576.00% (+0.57)
Nov 07, 2024
2024 (Q3)
<0.01 / -0.21
-0.05-320.00% (-0.16)
Aug 08, 2024
2024 (Q2)
-0.02 / -0.24
-0.01-2300.00% (-0.23)
May 02, 2024
2024 (Q1)
<0.01 / 0.06
0.15-60.00% (-0.09)
Mar 07, 2024
2023 (Q4)
0.01 / -0.75
0.04-1975.00% (-0.79)
Nov 09, 2023
2023 (Q3)
0.02 / -0.05
0.03-266.67% (-0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

JYNT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2025
$7.98$7.67-3.88%
Aug 07, 2025
$10.70$10.74+0.37%
May 08, 2025
$10.53$9.99-5.13%
Mar 13, 2025
$10.54$11.02+4.55%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Joint Corp (JYNT) report earnings?
Joint Corp (JYNT) is schdueled to report earning on Mar 05, 2026, After Close (Confirmed).
    What is Joint Corp (JYNT) earnings time?
    Joint Corp (JYNT) earnings time is at Mar 05, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is JYNT EPS forecast?
          JYNT EPS forecast for the fiscal quarter 2025 (Q4) is 0.04.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis